- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
ARCHIVE Published on: 2021-09-20
Legal and Scientific Basis
There is no legal or scientific basis for denying organ transplants to legal medical cannabis patients.
This widespread policy is not based on any state or federal regulations. There is no statue or regulation that would prevent a legal medical cannabis patient from receiving an anatomical gift, and neither UNOS or the Organ Procurement and Transplantation Network (OPTN) have guidelines or policies to that effect. Medical cannabis patients are most commonly denied for testing positive for using a drug of abuse. That policy predates the emerging science about the medical use of cannabis and its legalization in thirty-four states and the District of Columbia.
The policy of denying anatomical gifts to legal medical cannabis patients is also not based on science. Clinical research shows that medical cannabis and compounds in medical cannabis have beneficial immune-suppressive and anti-inflammatory effects.[i] Compounds in medical cannabis may prolong graft survival in transplant patients,[ii] and there is no association between cannabis use and lower survival rates.[iii] Furthermore, hypothetical concerns about the harmful effects of contaminates can be easily addressed by an emerging industry aimed at testing commercially available medical cannabis for molds, mildew, pesticides, etc.
[i] Rom, S., & Persidsky, Y. (2013). Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation. Journal of Neuroimmune Pharmacology. doi:10.1007/s11481-013-9445-9
[ii] Robinson, R. H., Meissler, J. J., Breslow-Deckman, J. M., Gaughan, J., Adler, M. W., & Eisenstein, T. K. (2013). Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction. Journal of Neuroimmune Pharmacology, 8(5), 1239–1250. doi:10.1007/s11481-013-9485-1
[iii] Ranney, D. N., Acker, W. B., Holou, Al, S. N., Ehrlichman, L., Lee, D. S., Lewin, S. A., et al. (2009). Marijuana Use in Potential Liver Transplant Candidates. American Journal of Transplantation, 9(2), 280–285. doi:10.1111/j.1600-6143.2008.02468.x